SAN DIEGO (AP) — SAN DIEGO (AP) — Travere Therapeutics, Inc. (TVTX) on Tuesday reported third-quarter profit of $150.7 million.
On a per-share basis, the San Diego-based company said it had profit of $1.97. Losses, adjusted to account for discontinued operations, came to $1.17 per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.09 per share.
The drug developer posted revenue of $37.1 million in the period, which also missed Street forecasts. Eight analysts surveyed by Zacks expected $132 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TVTX at https://www.zacks.com/ap/TVTX